메뉴 건너뛰기




Volumn 45, Issue 3-4, 1997, Pages 198-202

CD3 x CD19 bispecific antibodies and CD28 costimulation for locoregional treatment of low-malignancy non-Hodgkin's lymphoma

Author keywords

CD28; CD3 x CD19 bispecific antibodies; Locoregional treatment; Non Hodgkin's lymphoma

Indexed keywords

BISPECIFIC ANTIBODY; CD19 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; VINCRISTINE;

EID: 0030856803     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050432     Document Type: Article
Times cited : (22)

References (27)
  • 1
    • 0026493687 scopus 로고
    • G19.4(alpha CD3) × B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4; 11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells
    • Anderson PM, Crist W, Hasz D, Carroll AJ, Myers DE, Uckun FM (1992) G19.4(alpha CD3) × B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4; 11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells. Blood 80:2826
    • (1992) Blood , vol.80 , pp. 2826
    • Anderson, P.M.1    Crist, W.2    Hasz, D.3    Carroll, A.J.4    Myers, D.E.5    Uckun, F.M.6
  • 3
    • 0027196184 scopus 로고
    • Requirements for CD28-dependent T cell-mediated cytotoxicity
    • Azuma M, Cayabyab M, Phillips JH, Lanier LL (1993) Requirements for CD28-dependent T cell-mediated cytotoxicity. J Immunol 150:2091
    • (1993) J Immunol , vol.150 , pp. 2091
    • Azuma, M.1    Cayabyab, M.2    Phillips, J.H.3    Lanier, L.L.4
  • 4
    • 0028274563 scopus 로고
    • Potentiation of long-term-cultured lymphokine-activated killer cell cytotoxicity against small-cell lung carcinoma by anti-CD3 × anti-(tumour-associated antigen) bispecific antibody
    • Azuma A, Yagita H, Okumura K, Kudoh S, Niitani H (1994) Potentiation of long-term-cultured lymphokine-activated killer cell cytotoxicity against small-cell lung carcinoma by anti-CD3 × anti-(tumour-associated antigen) bispecific antibody. Cancer Immunol Immunother 38:294
    • (1994) Cancer Immunol Immunother , vol.38 , pp. 294
    • Azuma, A.1    Yagita, H.2    Okumura, K.3    Kudoh, S.4    Niitani, H.5
  • 5
    • 0027281795 scopus 로고
    • Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 × CD19 bispecific antibodies in combination with bivalent CD28 antibodies
    • Bohlen H, Hopff T, Manzke O, Engert A, Kube D, Wickramanayake PD, Diehl V, Tesch H (1993) Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 × CD19 bispecific antibodies in combination with bivalent CD28 antibodies. Blood 82:1803
    • (1993) Blood , vol.82 , pp. 1803
    • Bohlen, H.1    Hopff, T.2    Manzke, O.3    Engert, A.4    Kube, D.5    Wickramanayake, P.D.6    Diehl, V.7    Tesch, H.8
  • 6
    • 15644384495 scopus 로고    scopus 로고
    • Prevention of Epstein-Barr virus-induced human B cell lymphoma in severe combined immunodeficient mice treated with CD3 × CD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells
    • Bohlen H, Manzke O, Titzer S, Lorenzen J, Kube D, Engert A, Abken H, Wolf J, Diehl V, Tesch H (1997) Prevention of Epstein-Barr virus-induced human B cell lymphoma in severe combined immunodeficient mice treated with CD3 × CD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells. Cancer Res 57:1704
    • (1997) Cancer Res , vol.57 , pp. 1704
    • Bohlen, H.1    Manzke, O.2    Titzer, S.3    Lorenzen, J.4    Kube, D.5    Engert, A.6    Abken, H.7    Wolf, J.8    Diehl, V.9    Tesch, H.10
  • 9
    • 0028152942 scopus 로고
    • B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells
    • Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura K, Lanier LL, Banchereau J (1994) B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med 180:1841
    • (1994) J Exp Med , vol.180 , pp. 1841
    • Caux, C.1    Vanbervliet, B.2    Massacrier, C.3    Azuma, M.4    Okumura, K.5    Lanier, L.L.6    Banchereau, J.7
  • 10
    • 0028882034 scopus 로고
    • In vivo studies using bispecific antibodies (anti-CD3 × anti-idiotype) and CD28-induced costimulation in the BCL1 lymphoma
    • Demanet C, Brissinck J, De Jonge J, Thielemans K (1995) In vivo studies using bispecific antibodies (anti-CD3 × anti-idiotype) and CD28-induced costimulation in the BCL1 lymphoma. J Hematother 4:363
    • (1995) J Hematother , vol.4 , pp. 363
    • Demanet, C.1    Brissinck, J.2    De Jonge, J.3    Thielemans, K.4
  • 11
    • 0027142545 scopus 로고
    • Targeting of T lymphocytes against EGF-receptor+ tumour cells by bispecific monoclonal antibodies: Requirement of CD3 molecule cross-linking for T cell activiation
    • Ferrini S, Cambiaggi A, Sforzini S, Marciano S, Canevari S, Mezzanzanica D, Colnaghi MI, Grossi CE, Moretta L (1993) Targeting of T lymphocytes against EGF-receptor+ tumour cells by bispecific monoclonal antibodies: requirement of CD3 molecule cross-linking for T cell activiation. Int J Cancer 55:931
    • (1993) Int J Cancer , vol.55 , pp. 931
    • Ferrini, S.1    Cambiaggi, A.2    Sforzini, S.3    Marciano, S.4    Canevari, S.5    Mezzanzanica, D.6    Colnaghi, M.I.7    Grossi, C.E.8    Moretta, L.9
  • 12
    • 0028844025 scopus 로고
    • Performance of CD3 × CD19 bispecific monoclonal antibodies in B cell malignancy
    • Haagen IA (1995) Performance of CD3 × CD19 bispecific monoclonal antibodies in B cell malignancy. Leuk Lymphoma 19:381
    • (1995) Leuk Lymphoma , vol.19 , pp. 381
    • Haagen, I.A.1
  • 13
    • 0026537347 scopus 로고
    • CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
    • Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP (1992) CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607
    • (1992) Nature , vol.356 , pp. 607
    • Harding, F.A.1    McArthur, J.G.2    Gross, J.A.3    Raulet, D.H.4    Allison, J.P.5
  • 14
    • 0028337459 scopus 로고
    • Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function
    • Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ (1994) Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 180:631
    • (1994) J Exp Med , vol.180 , pp. 631
    • Hathcock, K.S.1    Laszlo, G.2    Pucillo, C.3    Linsley, P.4    Hodes, R.J.5
  • 15
  • 18
    • 0026758014 scopus 로고
    • Human cytotoxic T lymphocytes specific for autologous follicular lymphoma recognize immunoglobulin in a major histocompatibility complex restricted fashion
    • Luna-Fineman S, Lee JE, Wesley PK, Clayberger C, Krensky AM (1992) Human cytotoxic T lymphocytes specific for autologous follicular lymphoma recognize immunoglobulin in a major histocompatibility complex restricted fashion. Cancer 70:2181
    • (1992) Cancer , vol.70 , pp. 2181
    • Luna-Fineman, S.1    Lee, J.E.2    Wesley, P.K.3    Clayberger, C.4    Krensky, A.M.5
  • 19
    • 0031444874 scopus 로고    scopus 로고
    • Single-step purification of bispecific monoclonal antibodies for immunotherapeutic use by hydrophobic introduction chromatography
    • in press
    • Manzke O, Tesch H, Diehl V, Bohlen H (1997) Single-step purification of bispecific monoclonal antibodies for immunotherapeutic use by hydrophobic introduction chromatography. Journal of Immunological Methods (in press)
    • (1997) Journal of Immunological Methods
    • Manzke, O.1    Tesch, H.2    Diehl, V.3    Bohlen, H.4
  • 20
    • 0020518331 scopus 로고
    • Hybrid hybridomas and their use in immunohistochemistry
    • Milstein C, Cuello AC (1983) Hybrid hybridomas and their use in immunohistochemistry. Nature 305:537
    • (1983) Nature , vol.305 , pp. 537
    • Milstein, C.1    Cuello, A.C.2
  • 21
    • 0025161953 scopus 로고
    • Preliminary trial of specific targeting therapy against malignant glioma
    • Nitta T, Sato K, Yagita H, Okumura K, Ishii S (1990) Preliminary trial of specific targeting therapy against malignant glioma. Lancet 335:368
    • (1990) Lancet , vol.335 , pp. 368
    • Nitta, T.1    Sato, K.2    Yagita, H.3    Okumura, K.4    Ishii, S.5
  • 22
    • 0027165746 scopus 로고
    • Tolerance and ways to break it
    • Nossal GJ (1993) Tolerance and ways to break it. Ann N Y Acad Sci 690:34
    • (1993) Ann N Y Acad Sci , vol.690 , pp. 34
    • Nossal, G.J.1
  • 23
    • 0026016673 scopus 로고
    • Increased lysis of patient CD10-positive leukemic cells by T cells coated with anti-CD3 Fab′ antibody cross-linked to anti-CD10 Fab′ antibody
    • Oshimi K, Seto T, Oshimi Y, Masuda M, Okumura K, Mizoguchi H (1991) Increased lysis of patient CD10-positive leukemic cells by T cells coated with anti-CD3 Fab′ antibody cross-linked to anti-CD10 Fab′ antibody. Blood 77:1044
    • (1991) Blood , vol.77 , pp. 1044
    • Oshimi, K.1    Seto, T.2    Oshimi, Y.3    Masuda, M.4    Okumura, K.5    Mizoguchi, H.6
  • 25
    • 0028800647 scopus 로고
    • Bispecific monoclonal antibody therapy of B-cell malignancy
    • Weiner GJ, De Gast GC (1995) Bispecific monoclonal antibody therapy of B-cell malignancy. Leuk Lymphoma 16:199
    • (1995) Leuk Lymphoma , vol.16 , pp. 199
    • Weiner, G.J.1    De Gast, G.C.2
  • 26
    • 0024391086 scopus 로고
    • Characterization of the CD4+ and CD8+ tumour-infiltratin lymphocytes propagated with bispecific monoclonal antibodies
    • Wong JT, Pinto CE, Gifford JD, Kurnick JT, Kradin RL (1989) Characterization of the CD4+ and CD8+ tumour-infiltratin lymphocytes propagated with bispecific monoclonal antibodies. J Immunol 143:3404
    • (1989) J Immunol , vol.143 , pp. 3404
    • Wong, J.T.1    Pinto, C.E.2    Gifford, J.D.3    Kurnick, J.T.4    Kradin, R.L.5
  • 27
    • 0021227328 scopus 로고
    • A cloned T cell line cytotoxic for autologous and allogeneic B lymphoma cells
    • Yssel H, Spits H, De Vries J (1984) A cloned T cell line cytotoxic for autologous and allogeneic B lymphoma cells. J Exp Med 160:239
    • (1984) J Exp Med , vol.160 , pp. 239
    • Yssel, H.1    Spits, H.2    De Vries, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.